|
Vos collègues souhaitent rejoindre notre communauté et s'abonner à notre newsletter ? L'inscription se fait ici.
|
|
|
|
| Actualité de l'ITMO Cancer d'Aviesan |
|
| ITMO Cancer - AAP/AAC : Calendrier 2024 |
|
|
|
|
|
| Appels à projets ou à candidatures |
|
|
|
CLÔTURE IMMINENTE
4e année de thèse
Date limite de candidature : 12 Février 2024.
Consulter l'AAC.
Mobilité cliniciens
Date limite de candidature (session 1) : 12 Février 2024.
Consulter l'AAC.
Organisation de colloques
Date limite de candidature (session 1) : 27 Mars 2024.
Consulter l'AAC.
Doctorats
Ouverture du 10 Mai au 24 Juin 2024.
Consulter l'AAC.
|
|
|
|
|
|
| Inserm - AAC : Postes d'accueil 2024 |
|
CLÔTURE IMMINENTE
Les contrats « Postes d'Accueil » de l'Inserm permettent à de jeunes médecins, pharmaciens, odontologistes ou vétérinaires d'effectuer 2 ou 3 années à temps plein dans une unité de recherche de l'Inserm pour réaliser une thèse de sciences.
Date limite de candidature : 19 Février 2024 à 17h.
Consulter le guide du candidat.
Plus d'infos.
|
|
| INCa - AAP : PEDIAHRG 2024 |
|
CLÔTURE IMMINENTE
L'INCa lance son appel à projets de recherche High Risk-High Gain en cancérologie pédiatrique.
Date limite de candidature : 20 Février 2024 à 16h.
Consulter l'AAP.
Plus d'infos.
|
|
| Fondation ARC/SFC - AAC : Prix de mobilité internationale |
|
|
|
| ARDRM - AAC : Grands prix 2023 |
|
L'Association Robert-Debré pour la recherche médicale attribue 2 grands prix destinés à honorer les travaux de recherche d’équipes engagées dans la recherche biologique et médicale et à faciliter la poursuite et le développement de leurs projets.
Date limite de candidature : 29 Février 2024.
Consulter l'AAC.
|
|
|
|
Ce programme de l'Agence nationale de la recherche aide à financer le montage de réseaux scientifiques européens ou internationaux coordonnés par des équipes françaises. Le montage et l’animation d'un réseau doivent aboutir à l’élaboration et à la rédaction d’un projet de recherche, impliquant les membres du réseau, qui sera déposé à un appel à projets européen ou international clairement identifié dans le dossier de candidature.
Date limite de candidature (session 1) : 29 Février 2024 à 13h.
Consulter l'AAP.
Plus d'infos.
|
|
| EP PerMed - CFP: JTC 2024 |
|
|
|
| FRM - AAP : Amorçage jeunes équipes 2024 |
|
La Fondation pour la recherche médicale reconduit en 2024 son appel à projets destiné à de jeunes chercheurs, français ou étrangers, désireux de rejoindre une structure de recherche en France pour mettre en place et animer une nouvelle équipe de recherche.
Date limite de candidature (session 1) : 12 Avril 2024.
Consulter l'AAP.
Plus d'infos.
|
|
| Fondation ARC - AAP : Passerelle 2024 |
|
SAVE THE DATE
L'appel à projets "Passerelle" de la Fondation ARC a pour objectif de faciliter l’intégration en France des chercheurs en cancérologie les plus prometteurs. Il s’adresse à des chercheurs qui se préparent à se présenter à un concours de recrutement d'un EPST dans l’année qui suit l’attribution du financement Passerelle.
Ouverture de Février 2024 au 6 Juin 2024 à 15h.
Consulter l'AAP (à venir).
Plus d'infos.
|
|
| Fondation ARC - AAP : Pancréas 2024 |
|
SAVE THE DATE
L'appel à projets "Pancréas" de la Fondation ARC se concentrera en 2024 sur le microenvironnement tumoral, et particulièrement sur le stroma pancréatique.
Ouverture de Mars à Juin 2024.
Consulter l'AAP (à venir).
|
|
|
|
Le programme Soutien aux réseaux scientifiques européens ou internationaux de l'Agence nationale de la recherche aide des équipes françaises ayant déposé, en tant que coordinatrices, un projet de recherche à des appels collaboratifs européens (Horizon Europe) ou internationaux, à renforcer la qualité de leur candidature pour la dernière étape de l’appel visé.
Date limite de candidature : 31 Décembre 2024.
Consulter l'AAP.
Plus d'infos.
|
|
|
|
| SFTCG - Workshop: Gene Editing and Cell Therapy |
|
|
|
| Institut Curie - International Symposium of the Institute |
|
May 15th - 17th 2024, Paris
The Institut Curie will organise its 1st International Symposium "From Basic Science to Cancer Research", which will gather the scientific and medico-scientific community from all walks This Symposium will gather both the fundamental and the translational: geneticist, physicists, immunologists, chemists, chemical biologists, clinicians, and specialists in immunotherapy, DNA repair or immune cell metabolism.
NEW Registration.
NEW Programme.
More information.
|
|
| Pediac Program - Symposium: Pediatric Cancers |
|
May 29th - 31st 2024, Paris
The aim of this symposium organised by the Pediac Program teams is to bring together the pediatric cancer community to discuss advances in our understanding of the origins and causes of cancer development and the associated therapeutic perspectives.
Deadline for abstract submission: February 29th 2024.
More information.
|
|
| Cancéropôle PACA - Séminaire annuel |
|
4 & 5 Juillet 2024, Saint-Raphaël
Le programme de cette 11e édition du séminaire annuel du cancéropôle Provence-Alpes-Côte d'Azur proposera des sessions omics, intelligence artificielle ou encore oncopédiatrie ainsi qu’une sélection de communications orales, un concours de vulgarisation scientifique et des publications marquantes.
Date limite de candidature communication orales & concours de vulgarisation scientifique : 12 Mars 2024 à 17h.
Date limite d'inscription : 27 Mai 2024 à minuit.
Plus d'infos.
|
|
| CGO - Congress: EpiNantes 2024 |
|
September 24th - 25th 2024, Nantes
This international epigenetics meeting organised by the "Niches and Epigenetics of Tumors Network" of Canceropole Grand Ouest aims at informing the scientific community about recent and innovative research in epigenetics, both in the fundamental field and in medical/clinical applications.
Deadline for abstract submission (poster or oral presentation): July 1st 2024.
Deadline for early registration: May 1st 2024.
Programme.
More information.
|
|
| EMBO/EMBL - Symposium: Drug Resistance and Tolerance |
|
|
|
| Cours, Ateliers & Formations |
|
| Institut Curie/PSL - Course: Cell Biology and Cancer |
|
|
|
| EMBO - Workshop: Chromatin Biology in Cancer 2024 |
|
LAST DAYS FOR ABSTRACT SUBMISSION & REGISTRATION
April 23rd - 26th 2024, Singapore
The core objective of this European Molecular Biology Organisation workshop is to bring together outstanding researchers, from all around the world, at all stages in the field of epigenetics/chromatin biology with a focus on cancer for the exchange of ideas and information.
Deadline for abstract submission: February 14th 2024.
Deadline for registration: February 14th 2024.
Programme & More information.
|
|
| EMBO - Workshop: Intercepting Childhood Blood Cancer |
|
LAST DAYS FOR ABSTRACT SUBMISSION & REGISTRATION
May 3rd - 6th 2024, Düsseldorf (Germany)
This workshop organised by the European Molecular Biology Organisation will be dedicated to the theme 'Intercepting childhood blood cancer: from single cells to malignant clones'.
Deadline for abstract submission: February 15th 2024.
Deadline for registration: February 15th 2024.
Programme & More information.
|
|
|
|
| Inserm U1003 - Ingénieur(e) d'étude en immuno-oncologie |
|
L'équipe "Inflammasome et canaux ioniques" de l'unité PhyCell (Université de Lille/Inserm U1003, Institut de cancérologie de Lille) recrute un(e) ingénieur(e) d'étude en immuno-oncologie.
Date de prise de fonction : 1er Mars 2024.
Consulter l'offre.
|
|
| IGF Montpellier - IR or Post-Doc Position on glioblastoma |
|
The team Brain plasticity, stem cells and diffuse low-grade gliomas (Institut de génomique fonctionnelle, Montpellier) is seeking a candidate for a 2 year-funded research engineer (or postdoc). The project aims at studying the role of pathways and low grade gliomas drugs in the regulation of glioma stem cell fate and progression toward high grade gliomas (glioblastoma).
Deadline for application: December 2024.
See the Call.
|
|
|
|
| Appels à projets ou à candidatures |
|
| Fondation ARC - AAP : SIGN'IT 2024 |
|
L’objectif de l’appel à projets "Signatures en immunothérapie" de la Fondation ARC est de favoriser l’identification de signatures permettant de prédire la réponse d'une tumeur à un traitement par immunothérapie, et donc de guider la décision thérapeutique.
Date limite de candidature : 6 Mars 2024 à midi.
Consulter l'AAP.
Plus d'infos.
|
|
| Fondation ARC - AAP : Cancer & Vieillissement 2024 |
|
La Fondation ARC renouvelle son appel à projets « Cancer & Vieillissement » afin de soutenir des projets de recherche translationnelle consacrés à la compréhension des spécificités de la biologie des tumeurs chez les patients âgés.
Date limite de candidature : 12 Mars 2024 à 15h.
Consulter l'AAP.
Plus d'infos.
|
|
| Horizon Europe - CFP: ERC Proof of Concept Grants |
|
The European Research Council Proof of Concept Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to Principal Investigators whose proposals draw substantially on their ERC funded research.
Deadlines for application: March 14th 2024 & September 17th 2024, 17:00 (Brussels time)
More information.
|
|
| FRM - AAC : Aides individuelles 2024 |
|
Dans le cadre du programme généraliste "Espoirs de la recherche", la Fondation pour la recherche médicale lance son appel à candidatures "Aides individuelles" pour l'année 2024.
Consulter l'AAC.
Plus d'infos.
Poste de thèse pour internes et assistants
Date limite de candidature : 14 Mars 2024.
Aide au retour en France
Ouverture du 24 Avril au 23 Mai 2024.
Post-doctorat en France
Ouverture du 24 Avril au 23 Mai 2024.
|
|
| ANR - AAC : Chaire d'excellence en biologie/santé 2023 |
|
Dans le cadre du plan Innovation Santé 2030, l'Agence nationale de la recherche a lancé son appel à candidature "Chaire d’excellence en biologie/santé". Cette mesure a pour objectif d’offrir à des chercheurs de premier plan et de toutes origines des financements conséquents pour mener en France de nouveaux projets d’envergure.
Date limite de soumission des lettres d'intention (levée 3) : 23 Avril 2024 à 11h CEST.
Consulter l'AAC.
Plus d'infos.
|
|
| AMED/INCa - AAP : Programme de recherche collaborative ASPIRE |
|
SAVE THE DATE
L’Agence pour la recherche médicale et le développement du Japon et l'INCa lancent l'édition 2024 de l’appel à projets de recherche Adopting Sustainable Partnerships for an Innovative Research Ecosystem. Ce programme encourage la création de consortiums internationaux via l’octroi d’un financement principal de l’AMED, une partie importante des subventions étant dédiée à la mobilité internationale.
Ouverture de Mars à Mai 2024.
Plus d'infos.
|
|
| Inserm - AAC : Chaires 2024 |
|
SAVE THE DATE
L’Inserm ouvre en 2024 10 chaires, parmi lesquelles 4 concernent, en tout ou partie, la recherche sur le cancer.
Computational Modeling for Multi-Omics Data - Unité d'accueil : CRCM (Institut Paoli-Calmettes/CNRS/Aix-Marseille Université/Inserm U1068).
Consulter l'AAP.
Epitranscriptomics and Cancer Adaptation - Unité d'accueil : IRCM (Université de Montpellier/Inserm U1194).
Consulter l'AAP.
Bioengineering for Therapeutics - Unité d'accueil : Université de Nantes/Inserm U1089, U1229, U1307.
Consulter l'AAP.
Identification of Dysregulated Embryonal Programs in Pediatric Cancers - Unité d'accueil : Institut Curie/Université PSL/Inserm U830, Paris.
Consulter l'AAP.
Processus & Calendrier.
|
|
|
|
| ESMO - Congress: ESMO TAT 2024 |
|
February 26th - 28th 2024, Paris
The European Society for Medical Oncology congress on Targeted Anticancer Therapies will be dedicated to improving the conduct of early phase clinical trials in oncology by providing the latest scientific breakthroughs as well as workshops and educational reviews on pre-clinical and early clinical data.
Programme.
More information.
|
|
| EACR/AACR/IACR - Conference: How to Bring Basic Science Discoveries to the Clinic |
|
|
|
| PhilInBioMed - Meeting: 6th Philosophy of Cancer Biology Workshop |
|
March 4th - 6th 2024, Bordeaux
This workshop organised by the Institute for Philosophy in Biology and Medicine will focus on two topics:
- The role of the microbiota in cancer development and dissemination, a question that attracts increasing attention but remains challenging to address;
- The metastasis, which is considered as a major challenge for cancer treatment and a leading cause of cancer death, and for which innovative conceptual and theoretical frameworks are needed.
Programme & More information.
|
|
| CNRS/Inserm - Symposium: Advances in Glycosciences |
|
March 5th - 6th 2024, Paris
This symposium will focus on the latest innovations and concepts in basic glycosciences and their applications to biomedicine.
Registration.
Programme.
|
|
| EMBO/EMBL - Symposium: AI and Biology |
|
|
|
| INCa/Ligue/Fondation ARC - Séminaire : Restitution du PAIR Pédiatrie |
|
|
|
| EACR - Conference: The Tumour Ecosystem |
|
March 19th - 21st 2024, Bergamo (Italy)
This meeting organised by the European Association for Cancer Research will cover the latest breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. Novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy will be highlighted.
Programme.
More information.
|
|
| CIMT - Congress: 21st Annual Meeting |
|
May 15th - 17th 2024, Mainz (Germany)
This congress organised by the Association for Cancer Immunotherapy will cover preclinical to clinical developments on thetopics of cellular therapy, vaccines, immunomodulation, immunometabolism, tumor microenvironment, and immunobioinformatics, covering a wide range of areas in cancer immunotherapy.
Deadline for abstract submission: March 9th 2024.
Deadline for registration: March 23rd 2024.
Programme (coming soon).
More information.
|
|
| EACR - Conference: Cancer Multiomics and Computational Biology |
|
April 30th - May 2nd 2024, Bergamo (Italy)
This conference organised by the European Association for Cancer Research will cover the following domains:
- Machine learning and artificial intelligence to analyse and integrate multiomic data;
- Genomes and transcriptomes of cancers at single cell resolution;
- Cell tracking to monitor evolution and plasticity;
- Cancer evolution and immune evasion;
- Interpreting the cancer genome;
- Cancer epigenetics;
- Identification of (neo)antigenic landscape and specific antitumor T-cell response in human cancers;
- Spatial and 3D analysis of tumors at molecularly annotated single cell resolution.
Deadline for abstract submission: February 26th 2024.
Deadline for registration: March 25th 2024.
Programme.
More information.
|
|
| Fondation ARC - Colloque : Cancer & Vieillissement |
|
SAVE THE DATE
16 Mai 2024, Paris
Cet événement organisé par la Fondation ARC sera ouvert à tous les membres de la communauté scientifique et médicale, française et internationale, s'intéressant aux spécificités des cancers chez les patients âgés.
Programme et plus d'infos.
|
|
| Matwin - Convention: Meet2Win |
|
May 16th - 17th 2024, Bordeaux
Matwin will organise the 9th edition of its European Partnering Convention entirely dedicated to open innovation in oncology: A two-day partnering convention combining conferences, collaborative sessions, projects’ pitches, one-to-one prescheduled business meetings, etc.
Deadline for application: February 28th 2024.
Registration.
Programme.
More information.
|
|
| SUNRiSE - Congress: 5th Meeting of the Network |
|
May 29th - 31th 2024, Ajaccio
The 5th meeting of the SUNRiSE Network will be dedicated to the theme 'Heterogeneity and Plasticity in Cancer', with the most recent insights in the CSC field such as:
- Metabolic plasticity;
- CSC maintenance;
- Understanding and targeting tumor heterogeneity;
- Deciphering the interplay between CSC and tumor microenvironment.
Deadline for early bird registration: February 24th 2024.
Programme & More Information.
|
|
| EACR - Annual Congress 2024: Innovative Cancer Science |
|
June 10th - 13th 2024, Rotterdam (Netherlands)
The 2024 Annual Congress of the European Association for Cancer Research is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.
Deadline for abstract submission: March 4th 2024.
Deadline for early rate registration: April 29th 2024.
Programme.
More information.
|
|
| EMBO/EMBL - Symposium: Defining and Defeating Metastasis |
|
September 30th - October 3rd 2024, Heidelberg (Germany) & Virtual
This symposium organised by the European Molecular Biology Organisation and the European Molecular Biology Laboratory will cover emerging key concepts of latent metastasis and dissemination of tumor cells. Topics will address:
- Metastasis initiating cells, circulating tumour cells;
- Motility and invasion;
- Transcriptional and epigenetic control of metastasis;
- Metastasis heterogeneity, empithelial-mesenchymal transition and plasticity;
- Metastasis signalling and latency;
- Metastasis imaging, tumour microenvironment and immune evasion.
Deadline for registration: August 19th 2024 (on-site attending) & September 23rd 2024 (virtual attending).
More information.
|
|
| EACR - Conference: Cancer Metabolism |
|
|
|
| EACR - Conference: Liquid Biopsies |
|
November 12th - 14th 2024, Lyon
This European Association for Cancer Research conference will provide a comprehensive overview of liquid biopsies in cancer, with the following topics to be covered:
- Implementation of liquid biopsy in clinical trials;
- Applications for CTCs;
- Basic biology for biomarker discovery;
- New techniques enhancing liquid biopsy;
- Integration of multiple blood-based analytes for multimodal biomarkers;
- Artificial Intelligence applied to liquid biopsy.
Deadline for abstract submission: September 16th 2024.
Deadline for registration: October 14th 2024.
Programme.
More information.
|
|
| Cours, Ateliers & Formations |
|
| EMBO - Practical Course: Integrative Analysis of Multi-Omics Data |
|
|
|
| Institut Curie/PSL - Course: Epigenetics |
|
March 13th - 20th 2024, Paris
The aim of the course "Epigenetics: From nuclear organization to development in healthy and diseased states" organised by the Institut Curie/PSL University Training office is to provide an overview of epigenetic mechanisms and their links to gene expression and chromatin dynamics in different systems. Links between the disruption of nuclear functions and the development of human pathologies will be discussed. This year, focus will be on reprogramming aspects during development and in disease with a special emphasis on cancer.
Programme.
More information.
|
|
| Institut Curie/PSL - Course: Radiomics |
|
April 8th - 10th 2024, Paris
This international course "Radiomics: Theory & Practice", organised by the Institut Curie/PSL University Training office, will aim to explain what radiomics is, define best practices and teach how to use the free LIFEx software to analyze images and carry out radiomic studies.
Deadline for registration: March 1st 2024.
Programme.
More information.
|
|
| Institut Curie/PSL - Course: Non-Coding Genome |
|
May 22nd - 29th 2024, Paris
This international course, organised by the Institut Curie/PSL University Training office, will explore the versatility of non-genic DNA elements and non-coding RNAs across a spectrum of cellular processes, in humans and model organisms, and their implication in physiology and disease.
Deadline for registration: March 3rd 2024.
Programme.
More information.
|
|
| EMBO - Workshop: The Many Faces of Cancer Evolution |
|
May 29th - 31st 2024, Rimini (Italy)
This worshop organised by the European Molecular Biology Organisation will cover the following topics:
- Tumour evolution;
- Chromatin and description;
- Cell plasticity;
- Tumour heterogeneity;
- Epigenetics and gene regulation.
Deadline for abstract submission: April 15th 2024
Deadline for early bird registration: March 15th 2024.
Programme & More information.
|
|
| EMBO/FEBS - Lecture Course: Signal Transduction and Cancer |
|
August 18th - 26th 2024, Spetses (Greece)
This lecture course on the "Molecular Mechanisms in Signal Transduction and Cancer", organised by the European Molecular Biology Organisation and the Federation of European Biochemical Societies, will cover the following topics:
- Signaling by various pathways (PI3K, WNT, RAS/RAF);
- DNA damage and protein degradation signaling;
- Consequences of pathway deregulation for cellular processes like metabolism and damage repair;
- Application or translation of this knowledge into the clinic.
Deadline for abstract submission: April 1st 2024.
Deadline for registration: April 1st 2024.
Programme & More information.
|
|
| EMBO - Workshop: The Spatial Biology of Cancer |
|
SAVE THE DATE
September 1st - 3rd 2024, London (UK) & Virtual
More information (coming soon).
|
|
| EMBO - Workshop: Spatial Omics and Complexities of Human Diseases |
|
SAVE THE DATE
October 23rd - 25th 2024, Rome (Italy)
More information (coming soon).
|
|
| EMBO - Practical Course: Humanized Mice, Immunotherapy and Regenerative Medicine |
|
SAVE THE DATE
November 17th - 22nd 2024, Heidelberg (Germany)
This course organised by the European Molecular Biology Organisation will update the participants about different case-by-case models starting with the basic science, and how to best explore these models with accurate data acquisition and reporting.The topics chosen are:
- Immune reconstitution;
- Oncology;
- Immuno-Oncology;
- Regenerative Medicine;
- Infections.
Pre-programme & More information.
|
|
|
|
| IGBMC - AI en biologie moléculaire SVT |
|
|
|
| IGBMC - Post-Doc Positions |
|
|
|
| LabEx TOUCAN/IPBS - Post-Doc Position |
|
|
|
| CRSA - 4-year Post-Doc Position |
|
|
|
| Unité CHIP (U830) - Ingénieur(e) & Post-Doc |
|
L'équipe Genomics and Development of Childhood Cancers de l'unité "Cancer, hétérogénéité, instabilité et plasticité" (Institut Curie/Université PSL/Inserm U830) recrute :
- un(e) ingénieur(e) en bioinformatique
Consulter l'offre.
- un(e) post-doc en bioinformatique/génomique
Consulter l'offre.
|
|
| Institut Imagine - AI ou IE en biologie/sciences de la vie |
|
Le groupe Mécanismes moléculaires des pathologies de l'hématopoïèse et biothérapies (Institut Imagine) recrute un.e assistant.e ingénieur.e ou ingénieur.e d'étude pour travailler sur la fonction d'un gène lié à l'apoptose dans deux maladies hématopoïétiques rares : le syndrome lymphoprolifératif auto-immun et la mastocytose.
Consulter l'offre.
|
|
| CRBM - Post-Doc Position on HCC |
|
The team Cancer Cell Signalling in the Centre de recherche en biologie cellulaire de Montpellier is looking for a young scientist to work on a new oncogenic mechanism in hepatoellular carcinoma.
See the Call.
Contact.
|
|
| Inserm U 1109 - Post-Doc Position |
|
|
|
| Télécharger au format PDF |
